FENOFRA
The computed 12-month bankruptcy probability of FENOFRA is 2.9% (moderate). The 2025 annual accounts show negative equity (€-40k) and a net result of €-30k. Equity is shrinking by ~205.9% per year across the filed fiscal years. Its solvency ranks better than 18% of 17540 sector peers (fiscal year 2025). The company has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €-40k |
| Net result | €-30k |
| Staff (FTE) | 2.9 |
| Better than sector | 18% |
Mixed profile: strong on profitability, weaker on health.
All 5 axes are computed from data Checked has read.
How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | -14.7% | 34.6% | |
| Net result | €-30k | €5k | |
| Equity | €-40k | €44k | |
| Gross operating margin | €93k | €34k | |
| Staff costs | €78k | €40k |
Figures by fiscal year and ratios
| Fiscal year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Deposit | micro schema | micro schema | micro schema |
| Revenue | - | - | - |
| EBITDA | €13k | €31k | €-14k |
| Net profit | €-30k | €-10k | €-60k |
| Cash flow | €4k | €23k | €-26k |
| Staff costs | €78k | €86k | €56k |
| Income taxes | - | - | €103 |
| Dividends | - | - | - |
| Total assets | €270k | €343k | €318k |
| Equity | €-40k | €-10k | €471 |
| Debt | €310k | €353k | €318k |
| of which ≤ 1y | €248k | €264k | €201k |
| of which > 1y | €62k | €89k | €116k |
| Working capital | €-119k | €-91k | €-79k |
| Employees (FTE) | 2.9 | 3.3 | 2.7 |
| 2025 | 2024 | 2023 | |
|---|---|---|---|
| Current ratio | 0.52 | 0.65 | 0.61 |
| Quick ratio | 0.19 | 0.31 | 0.13 |
| Working capital ratio | -44.0% | -26.6% | -24.8% |
| Solvency | -14.7% | -2.8% | 0.1% |
| Debt / equity | -7.81 | -36.19 | 674.31 |
| Long-term debt ratio | -1.57 | -9.17 | 246.41 |
| Interest coverage | 1.26 | 3.49 | -1.07 |
| Gross margin | - | - | - |
| Net margin | - | - | - |
| ROA | -11.1% | -3.0% | -18.7% |
| ROE | 75.4% | 104.8% | -12642.6% |
| EBITDA margin | - | - | - |
| Days sales outstanding | - | - | - |
| Days payable outstanding | - | - | - |
| Inventory turnover | - | - | - |
| Days inventory (DSI) | - | - | - |
Full annual accounts (26 line items)
| Line item | Code | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Balance sheet, Assets | ||||
| TOTAL ASSETS | 20/58 | €270k | €343k | €318k |
| Fixed assets | 21/28 | €141k | €170k | €194k |
| Formation expenses | 20 | €552 | €846 | €1k |
| Intangible fixed assets | 21 | €89k | €112k | €135k |
| Tangible fixed assets | 22/27 | €35k | €41k | €43k |
| Financial fixed assets | 28 | €16k | €16k | €16k |
| Current assets | 29/58 | €129k | €172k | €123k |
| Stocks & contracts in progress | 3 | €81k | €90k | €96k |
| Amounts receivable within one year | 40/41 | €6k | €5k | €5k |
| Cash & bank | 54/58 | €39k | €77k | €17k |
| Balance sheet, Equity & liabilities | ||||
| TOTAL EQUITY & LIABILITIES | 10/49 | €270k | €343k | €318k |
| Equity | 10/15 | €-40k | €-10k | €471 |
| Contributions / capital | 10/11 | €60k | €60k | €60k |
| Accumulated profits (losses) | 14 | €-100k | €-70k | €-60k |
| Amounts payable | 17/49 | €310k | €353k | €318k |
| Amounts payable after one year | 17 | €62k | €89k | €116k |
| Amounts payable within one year | 42/48 | €248k | €264k | €201k |
| Trade debts payable within one year | 44 | €181k | €192k | €131k |
| Income statement | ||||
| Gross operating margin | 9900 | €93k | €118k | €45k |
| Operating result | 9901 | €-21k | €-2k | €-47k |
| Financial income | 75 | €2k | €934 | €664 |
| Financial charges | 65 | €10k | €9k | €13k |
| Result before taxes | 9903 | €-30k | €-10k | €-59k |
| Income taxes | 67/77 | - | - | €103 |
| Net result for the period | 9904 | €-30k | €-10k | €-60k |
| Result to be appropriated | 9905 | €-30k | €-10k | €-60k |
| NACE primary | Non-specialised retail sale with food, beverages or tobacco predominating(47110) |
| Legal form | Private limited company(610) |
| Incorporation | 18-05-2022 |
| Status | Active |
| Postal code | 9000 |
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 44809I0711/00W005 | Flanders | 417 m² | 1 · 410 m² | 21.4 m · 4 fl. |
We know of 1 Belgian State Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.
| Legal nameNL | FENOFRA |